Celltrion Healthcare receives EC approval for the first high concentration, low-volume and citrate-free biosimilar adalimumab, Y admin Wed, 02/17/2021 - 16:50
source https://www.pharmatutor.org/content/february-2021/celltrion-healthcare-receives-ec-approval-for-the-first-high-concentration-low-volume-and-citrate-free-biosimilar-adalimumab-y
Subscribe to:
Post Comments (Atom)
-
Vacancy for Ph.D in life sciences at Indian Institute of Technology admin Wed, 01/20/2021 - 16:59 source https://www.pharmatutor.org/con...
-
Results from a clinical trial published in 2011 confirmed the benefit of using Avastin over laser therapy for treating the most severe c...
-
National Institute for Research in Reproductive Health (NIRRH), formerly known as Institute for Research in Reproduction is a premier res...
No comments:
Post a Comment